A New Voice for Autism Research in Washington

The Independent Autism Coordinating Committee, or I‑ACC, met for the first time in Washington, D. C. , offering a fresh take on autism science after recent changes to the federal Interagency Autism Coordinating Committee. The I‑ACC was formed quickly by researchers and advocates who felt the official committee had lost its scientific footing. They highlighted that 21 new members appointed by Secretary Robert F. Kennedy, Jr. include people who link vaccines to autism and support unproven treatments. These appointments raised concerns that the federal committee now represents only a small, skeptical group rather than the broader autism community. At its kickoff meeting, I‑ACC members discussed missing research priorities: better funding for rigorous therapy trials, improved communication tools, and answers to questions about using certain antidepressants with autistic children. The federal committee was scheduled to meet the same day but postponed after hearing about I‑ACC’s gathering. This postponement underscored how the new group’s existence directly challenged the status quo set by Kennedy’s overhaul.Critics point out that under Kennedy, CDC and FDA websites were altered to cast doubt on vaccine safety and remove warnings about dangerous autism therapies like chelation. These shifts are seen as part of a broader effort to revive vaccine skepticism. The I‑ACC’s mission is to keep research focused on evidence and to protect taxpayer dollars from being wasted on fringe ideas. Its members argue that the federal committee’s current composition could slow scientific progress and harm people with autism. The original federal I‑ACC was created in 2006 to address rising concerns about vaccines and autism, aiming to bring researchers, families, and autistic individuals together. The new committee seeks to restore that collaborative spirit by countering ideological bias. Both groups currently have limited representation of autistic people, with the federal committee having fewer members and I‑ACC only one. Many feel this weakens the community’s voice in shaping research priorities. Critics warn that without strong advocacy, autistic people risk losing influence over the policies and studies that affect their lives.